Journal Article DKFZ-2026-00834

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
At what age should people with obesity start colorectal cancer screening?

 ;  ;  ;  ;

2026
Wiley-Liss Bognor Regis

International journal of cancer nn, nn () [10.1002/ijc.70448]
 GO

Abstract: The incidence of obesity and early-onset colorectal cancer (CRC) has rapidly increased in recent decades. We estimated CRC risk differences by body mass index (BMI) and derived corresponding BMI-specific CRC screening initiation ages across multiple countries, to help refine the timing of CRC prevention. We based our analyses on population-level CRC incidence data from the GLOBOCAN database (2022) and risk estimates from a meta-analysis of six cohort studies. The analysis included adults aged 30 to 60 years from six countries: United States, Canada, Germany, France, United Kingdom, and Italy. Individuals with overweight were used as the reference category, reflecting the average BMI of adults eligible for screening in these countries. Risk-adapted screening initiation ages were defined as the ages at which individuals with obesity reached the same 5-year cumulative CRC risk as those with overweight at ages 45 and 50 (aCR45 and aCR50). Compared with individuals with overweight, those with normal weight had a lower risk of early-onset CRC (OR, 0.76; 95% CI, 0.68-0.84), while those with obesity had higher risk (OR, 1.42; 95% CI, 1.04-1.95). Across countries, individuals with obesity reached the aCR45 at age 41 to 42 years and the aCR50 at age 46 to 47 years. These findings indicate that individuals with obesity reached CRC screening thresholds up to 3-4 years earlier than those at average risk. BMI may offer a practical and scalable marker to inform personalized CRC screening initiation, with the potential to enhance early detection if integrated into existing screening programs.

Keyword(s): body mass index ; early detection ; early‐onset colorectal cancer ; screening

Classification:

Note: #EA:C070#LA:M320# / epub

Contributing Institute(s):
  1. C070 Klinische Epidemiologie der Krebsfrüherkennung (C070)
Research Program(s):
  1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2026
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Wiley ; Essential Science Indicators ; IF >= 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2026-04-10, last modified 2026-04-10



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)